<p>Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Early Breast Cancer presented at the 2025 ASCO Annual Meeting.</p> <p> </p> <p> </p> <p><strong>VIEW THE TOPICS: </strong></p> <p>•     Adjuvant Systemic Therapy for Early-stage HR+/HER2- Breast Cancer<br /> •     CDK4/6 Inhibitor Therapy in Early-stage HR+/HER2- Breast Cancer<br /> •     Considerations for Treating Older Adults With Early-stage HR+/HER2- Breast Cancer<br /> •     Gene Expression Profiling for Early-stage HR+/HER2- Breast Cancer</p> <div class="overview"> <p> </p> </div> <div class="body-content"> <p><em>This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.</em></p> </div> <p> </p> <p style="text-align: center;">2025 ASCO Annual Meeting</p> <p style="text-align: center;">May 30 – June 3, 2025</p> <p style="text-align: center;">McCormick Place, Chicago, IL & Online</p> <p style="text-align: center;"><a href="https://meetings-registration.asco.org/registration-and-housing/327/meeting_registration?intcmp=nw_ascoorg_am_am25_site_amlandingpage_all__glob_041625__qklnk__aware_image_">Link to Registration</a></p>